(ATS) ATS - Overview
Stock: Automation Systems, Software Solutions, Lifecycle Services, Digital Factory
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 38.3% |
| Relative Tail Risk | -9.16% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.24 |
| Alpha | -16.33 |
| Character TTM | |
|---|---|
| Beta | 1.522 |
| Beta Downside | 1.168 |
| Drawdowns 3y | |
|---|---|
| Max DD | 56.76% |
| CAGR/Max DD | -0.16 |
Description: ATS ATS January 10, 2026
ATS Corporation (NYSE:ATS) designs, builds, and services automated manufacturing and assembly systems for a broad range of industries, including life sciences, transportation, consumer goods, and energy. Its end-to-end offering spans pre-automation consulting (discovery, simulation, TCO modeling), system integration (engineering, procurement, installation), and post-automation support (training, predictive maintenance, spare parts, retrofits). The firm also provides software-driven “connected factory” solutions that capture real-time machine data to reduce downtime and improve operational efficiency.
Key recent metrics: FY2023 revenue reached roughly $1.6 billion with an operating margin of ~8 %, and the company reported a backlog of about $2.2 billion, indicating strong order flow. Growth is being driven by rising industrial-automation spend (global CAGR ≈ 6 % through 2027) and heightened demand for automation in life-sciences manufacturing amid expanding biotech pipelines. Supply-chain resilience and labor shortages remain sector-wide risks that could affect project timelines and cost structures.
For a deeper dive into ATS’s valuation metrics and peer comparison, you might find ValueRay’s analytical platform useful.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: -4.65m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 5.71 > 1.0 |
| NWC/Revenue: 36.92% < 20% (prev 34.49%; Δ 2.43% < -1%) |
| CFO/TA 0.06 > 3% & CFO 290.3m > Net Income -4.65m |
| Net Debt (1.48b) to EBITDA (200.6m): 7.37 < 3 |
| Current Ratio: 1.92 > 1.5 & < 3 |
| Outstanding Shares: last quarter (98.0m) vs 12m ago -0.41% < -2% |
| Gross Margin: 25.95% > 18% (prev 0.29%; Δ 2566 % > 0.5%) |
| Asset Turnover: 59.17% > 50% (prev 64.33%; Δ -5.16% > 0%) |
| Interest Coverage Ratio: 0.55 > 6 (EBITDA TTM 200.6m / Interest Expense TTM 104.4m) |
Altman Z'' 2.61
| A: 0.21 (Total Current Assets 2.07b - Total Current Liabilities 1.08b) / Total Assets 4.67b |
| B: 0.16 (Retained Earnings 729.3m / Total Assets 4.67b) |
| C: 0.01 (EBIT TTM 57.8m / Avg Total Assets 4.55b) |
| D: 0.59 (Book Value of Equity 1.72b / Total Liabilities 2.91b) |
| Altman-Z'' Score: 2.61 = A |
Beneish M -2.90
| DSRI: 1.19 (Receivables 1.37b/1.22b, Revenue 2.69b/2.85b) |
| GMI: 1.11 (GM 25.95% / 28.81%) |
| AQI: 0.97 (AQ_t 0.46 / AQ_t-1 0.48) |
| SGI: 0.94 (Revenue 2.69b / 2.85b) |
| TATA: -0.06 (NI -4.65m - CFO 290.3m) / TA 4.67b) |
| Beneish M-Score: -2.90 (Cap -4..+1) = A |
What is the price of ATS shares?
Over the past week, the price has changed by +6.77%, over one month by +3.99%, over three months by +9.27% and over the past year by +2.85%.
Is ATS a buy, sell or hold?
- StrongBuy: 1
- Buy: 5
- Hold: 2
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the ATS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 35 | 16.9% |
| Analysts Target Price | 35 | 16.9% |
| ValueRay Target Price | 29.6 | -1.2% |
ATS Fundamental Data Overview February 04, 2026
P/E Forward = 17.5747
P/S = 1.0104
P/B = 2.0961
Revenue TTM = 2.69b CAD
EBIT TTM = 57.8m CAD
EBITDA TTM = 200.6m CAD
Long Term Debt = 1.39b CAD (from longTermDebt, last quarter)
Short Term Debt = 35.1m CAD (from shortTermDebt, last quarter)
Debt = 1.74b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.48b CAD (from netDebt column, last quarter)
Enterprise Value = 5.19b CAD (3.71b + Debt 1.74b - CCE 263.2m)
Interest Coverage Ratio = 0.55 (Ebit TTM 57.8m / Interest Expense TTM 104.4m)
EV/FCF = 23.55x (Enterprise Value 5.19b / FCF TTM 220.5m)
FCF Yield = 4.25% (FCF TTM 220.5m / Enterprise Value 5.19b)
FCF Margin = 8.19% (FCF TTM 220.5m / Revenue TTM 2.69b)
Net Margin = -0.17% (Net Income TTM -4.65m / Revenue TTM 2.69b)
Gross Margin = 25.95% ((Revenue TTM 2.69b - Cost of Revenue TTM 1.99b) / Revenue TTM)
Gross Margin QoQ = 30.05% (prev 29.84%)
Tobins Q-Ratio = 1.11 (Enterprise Value 5.19b / Total Assets 4.67b)
Interest Expense / Debt = 1.40% (Interest Expense 24.4m / Debt 1.74b)
Taxrate = 33.82% (17.2m / 50.8m)
NOPAT = 38.2m (EBIT 57.8m * (1 - 33.82%))
Current Ratio = 1.92 (Total Current Assets 2.07b / Total Current Liabilities 1.08b)
Debt / Equity = 0.99 (Debt 1.74b / totalStockholderEquity, last quarter 1.75b)
Debt / EBITDA = 7.37 (Net Debt 1.48b / EBITDA 200.6m)
Debt / FCF = 6.71 (Net Debt 1.48b / FCF TTM 220.5m)
Total Stockholder Equity = 1.73b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.10% (Net Income -4.65m / Total Assets 4.67b)
RoE = -0.27% (Net Income TTM -4.65m / Total Stockholder Equity 1.73b)
RoCE = 1.85% (EBIT 57.8m / Capital Employed (Equity 1.73b + L.T.Debt 1.39b))
RoIC = 1.18% (NOPAT 38.2m / Invested Capital 3.23b)
WACC = 8.14% (E(3.71b)/V(5.46b) * Re(11.52%) + D(1.74b)/V(5.46b) * Rd(1.40%) * (1-Tc(0.34)))
Discount Rate = 11.52% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.76%
[DCF Debug] Terminal Value 69.60% ; FCFF base≈220.5m ; Y1≈144.8m ; Y5≈66.0m
Fair Price DCF = N/A (negative equity: EV 1.26b - Net Debt 1.48b = -218.4m; debt exceeds intrinsic value)
EPS Correlation: -31.54 | EPS CAGR: 14.56% | SUE: 0.08 | # QB: 0
Revenue Correlation: 40.62 | Revenue CAGR: 7.95% | SUE: N/A | # QB: 0
EPS next Year (2027-03-31): EPS=1.59 | Chg30d=+0.021 | Revisions Net=+3 | Growth EPS=+24.1% | Growth Revenue=+5.0%